SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)-IMIDAZO[1,2-B][1,2,4]TRIAZIN-2-YL]BENZAMIDE AND PROCESSES RELATED TO PREPARING THE SAME
    4.
    发明申请
    SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)-IMIDAZO[1,2-B][1,2,4]TRIAZIN-2-YL]BENZAMIDE AND PROCESSES RELATED TO PREPARING THE SAME 有权
    2-氟-N-甲基-4- [7-(喹啉-6-基甲基) - 咪唑并[1,2-B] [1,2,4]三嗪-2-基]苯甲酰胺和方法的相关 准备相同

    公开(公告)号:US20130289036A1

    公开(公告)日:2013-10-31

    申请号:US13793864

    申请日:2013-03-11

    IPC分类号: C07D487/04

    摘要: The present invention is directed to dihydrochloric acid and dibenzenesulfonic acid salts of the c-Met kinase inhibitor 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, and pharmaceutical compositions thereof, useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways. The present invention further relates to processes and intermediates for preparing 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, and salts thereof.

    摘要翻译: 本发明涉及c-Met激酶抑制剂2-氟-N-甲基-4- [7-(喹啉-6-基甲基) - 咪唑并[1,2-b] [1]的二氯氯酸和二苯磺酸盐 ,2,4]三嗪-2-基]苯甲酰胺及其药物组合物,其可用于治疗与激酶途径失调相关的癌症和其它疾病。 本发明还涉及制备2-氟-N-甲基-4- [7-(喹啉-6-基甲基)咪唑并[1,2-b] [1,2,4]三嗪-2-酮的方法和中间体, 吡啶-2-基]苯甲酰胺及其盐。

    Ketone substituted benzimidazole compounds
    6.
    发明申请
    Ketone substituted benzimidazole compounds 审中-公开
    酮取代的苯并咪唑化合物

    公开(公告)号:US20050176792A1

    公开(公告)日:2005-08-11

    申请号:US11035876

    申请日:2005-01-07

    CPC分类号: C07D235/30

    摘要: Disclosed are ketone substituted benzimidazole compounds of formula(I): wherein R1, R2, R3, R4 and Xa are defined herein. The compounds of the invention inhibit Itk kinase and are therefore useful for treating diseases and pathological conditions involving inflammation, immunological disorders and allergic disorders. Also disclosed are processes for preparing these compounds and to pharmaceutical compositions comprising these compounds.

    摘要翻译: 公开了式(I)的酮取代的苯并咪唑化合物:其中R 1,R 2,R 3,R 4, SUB>和X< a>在本文中定义。 本发明的化合物抑制Itk激酶,因此可用于治疗涉及炎症,免疫学障碍和过敏性疾病的疾病和病理状况。 还公开了制备这些化合物的方法和包含这些化合物的药物组合物。